OCC 2.78% 35.0¢ orthocell limited

FDA significance, page-490

  1. 7,514 Posts.
    lightbulb Created with Sketch. 6768

    Skeksil,

    No need to apologise, I welcome informed dissent. Confirmation bias does no-one any good. I don't welcome self-admitted drunken taunts and deliberate efforts to "pick a fight". Your view on ATI seems to have changed considerably to the criticisms you made in the past, when apparently not having even read the trial protocols. I've put the olive branch out in the past and am quite happy to leave it all in the past.

    You mentioned the massive disappointment of the Ligament Augmentation and Reconstruction System (LARS) ACL reconstruction graft. Like yourself I have reported the issues, debris requiring surgery particularly on failed repairs. We have CelGro Rope ACL pre-clinical study results in the next two weeks. I am am sure many investors would enjoy any informed input you can give us therein - negative or positive.
    Last edited by bedger: 15/09/21
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
35.0¢
Change
-0.010(2.78%)
Mkt cap ! $73.26M
Open High Low Value Volume
36.0¢ 36.0¢ 35.0¢ $82.13K 232.2K

Buyers (Bids)

No. Vol. Price($)
7 92207 35.0¢
 

Sellers (Offers)

Price($) Vol. No.
35.5¢ 27779 1
View Market Depth
Last trade - 16.10pm 08/07/2024 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.